View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
February 10, 2017

Pharma marketers must embrace digital or be left in the dark

The digital age has created a raft of new expectations from healthcare providers and patients, and pharma needs to adapt quickly.

By GBI Research

The digital age has created a raft of new expectations from healthcare providers and patients, and pharma needs to adapt quickly. Over 40% of consumers state that information from social media affects their health decisions. Physician preferences are also changing – 75% of healthcare providers now want and expect digital content from pharma providers.

Free Whitepaper
img

Never Trust, Always Verify: Is Zero Trust the Next Big Thing in Cybersecurity?

Cyberattacks continue to rise every year and no sector seems to be immune. Hackers target sensitive information such as organizational, client, and financial data, as well as intellectual property (IP) and proprietary functions. As digital transformation becomes a top priority for many organizations, traditional perimeter-based security models are no longer sufficient to address the growing cybersecurity concerns. Against the backdrop, enterprises explore zero trust as it takes a micro-level approach to authenticate and approve access at every point within a network. Reasons to read: The cybersecurity landscape is swiftly changing, and businesses need more awareness to meet the evolving change. The report highlights the current state of play and the future potential of the zero trust approach in cybersecurity to protect critical digital infrastructure of enterprises across sectors such as financial services, healthcare, telecom, and transportation, among others. Read our report and gather insights on the following topics:
  • Traditional vs zero trust protection
  • Key advantages and solution providers
  • Major industries and key players
  • Drivers and challenges
  • Top funded startups and Mergers & Acquisitions
  • Implementation challenges
by GlobalData
Enter your details here to receive your free Whitepaper.

In addition, the effectiveness of pharma’s traditionally favoured marketing channel – face-to-face meetings between sales reps and physicians – is decreasing. This has resulted in job losses in recent years, including a 30% reduction of US sales reps by Eli Lilly in 2013, and the cutting of 1,600 reps by AstraZeneca in 2016. 

A wealth of options

GBI Research’s latest report examines various digital strategies that pharma companies can implement in order to maintain return on investment in the face of a changing marketing landscape. The use of digital channels, in conjunction with traditional methods as part of a synergistic multichannel marketing strategy, can help boost growth, increase efficiency and reduce costs. For example, the use of tablet devices in ‘detailing’ between sales reps and physicians saves sales reps 250 hours a year, allowing for 35,000 more customer visits. Channels such as mobile apps enable pharma companies to reach vast audiences on a regular basis –Sanofi’s GoMeals diabetes app has been downloaded over 850,000 times.

Time for change

While the pharmaceutical industry readily adopts new approaches to provide medical advancements, it has been much slower to adopt technology within its marketing efforts.  With the radical changes in expectations created by mobile technology and social media, pharma can no longer afford to be hesitant. The companies that invest in digital marketing now will be the ones that succeed tomorrow.

Related Companies

Free Whitepaper
img

Never Trust, Always Verify: Is Zero Trust the Next Big Thing in Cybersecurity?

Cyberattacks continue to rise every year and no sector seems to be immune. Hackers target sensitive information such as organizational, client, and financial data, as well as intellectual property (IP) and proprietary functions. As digital transformation becomes a top priority for many organizations, traditional perimeter-based security models are no longer sufficient to address the growing cybersecurity concerns. Against the backdrop, enterprises explore zero trust as it takes a micro-level approach to authenticate and approve access at every point within a network. Reasons to read: The cybersecurity landscape is swiftly changing, and businesses need more awareness to meet the evolving change. The report highlights the current state of play and the future potential of the zero trust approach in cybersecurity to protect critical digital infrastructure of enterprises across sectors such as financial services, healthcare, telecom, and transportation, among others. Read our report and gather insights on the following topics:
  • Traditional vs zero trust protection
  • Key advantages and solution providers
  • Major industries and key players
  • Drivers and challenges
  • Top funded startups and Mergers & Acquisitions
  • Implementation challenges
by GlobalData
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology